Globus Medical completed the acquisition of Nevro for $250m.

Globus Medical, a global musculoskeletal company, completed the acquisition of Nevro, a medical device company delivering pain relief solutions for patients suffering from low back pain and other types of chronic pain, for $250m. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,” Kevin Thornal, Nevro CEO and President.